Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 8/20 | 0.48 |
| ▸ | CTSD | P07339 | 3/20 | 0.47 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.46 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.46 |
| ▸ | NPY4R | P50391 | 3/20 | 0.45 |
| ▸ | NPY1R | P25929 | 2/20 | 0.45 |
| ▸ | NPY2R | P49146 | 2/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.45 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30262036 | 0.93 | VIPR1 (0.52) | BACE1VIPR2KISS1RVIPR1 | |
| SCHEMBL29694507 | 0.91 | VIPR2 (0.56) | VIPR2VIPR1 | |
| SCHEMBL31410839 | 0.91 | BACE1 (0.48) | BACE1CTSDVIPR2KISS1RNPY4R | |
| SCHEMBL31344448 | 0.91 | NPY4R (0.49) | BACE1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31484239 | 0.89 | BACE1 (0.49) | BACE1CTSDNPY4RNPY1RNPY2R | |
| SCHEMBL31484224 | 0.89 | BACE1 (0.49) | BACE1CTSDNPY4RNPY1RNPY2R | |
| SCHEMBL30786594 | 0.89 | NPY4R (0.47) | VIPR2NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29777785 | 0.89 | VIPR2 (0.49) | BACE1CTSDVIPR2NPY4RNPY1R | |
| SCHEMBL30262050 | 0.89 | TFPI (0.50) | BACE1CTSDKISS1RVIPR1 | |
| SCHEMBL30544308 | 0.89 | NPY4R (0.51) | BACE1CTSDKISS1RNPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1844070-A1 | PEPTIDES WITH NEUROPEPTIDE-2 RECEPTOR (Y2R) AGONIST ACTIVITY | F.HOFFMANN-LA ROCHE AG (CH) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006077035-A9 | PEPTIDES WITH NEUROPEPTIDE-2 RECEPTOR (Y2R) AGONIST ACTIVITY | HOFFMANN LA ROCHE (CH) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006077035-A1 | PEPTIDES WITH NEUROPEPTIDE-2 RECEPTOR (Y2R) AGONIST ACTIVITY | F.HOFFMANN-LA ROCHE AG (CH) | 2006-07-27 | — | — | WO | disclosed |